MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,529,130 | +20.1% | 35,104 | -0.4% | 0.01% | +25.0% |
| Q2 2023 | $1,273,727 | -16.1% | 35,254 | -13.6% | 0.00% | -20.0% |
| Q1 2023 | $1,517,650 | -11.7% | 40,819 | +7.6% | 0.01% | -16.7% |
| Q4 2022 | $1,719,650 | -37.8% | 37,953 | -4.2% | 0.01% | -33.3% |
| Q3 2022 | $2,766,000 | -1.7% | 39,604 | -5.5% | 0.01% | +28.6% |
| Q2 2022 | $2,813,000 | -1.8% | 41,904 | +20.2% | 0.01% | +16.7% |
| Q1 2022 | $2,866,000 | +4.4% | 34,852 | +86.3% | 0.01% | +20.0% |
| Q4 2021 | $2,745,000 | -16.3% | 18,711 | +0.9% | 0.01% | -28.6% |
| Q3 2021 | $3,279,000 | +10.9% | 18,537 | +1.3% | 0.01% | +16.7% |
| Q2 2021 | $2,957,000 | -75.8% | 18,305 | -74.3% | 0.01% | -76.9% |
| Q1 2021 | $12,200,000 | -39.0% | 71,218 | -21.8% | 0.03% | -43.5% |
| Q4 2020 | $20,014,000 | +53.3% | 91,123 | +15.9% | 0.05% | +39.4% |
| Q3 2020 | $13,053,000 | +45.5% | 78,606 | 0.0% | 0.03% | +32.0% |
| Q2 2020 | $8,974,000 | +77.9% | 78,606 | +19.8% | 0.02% | +47.1% |
| Q1 2020 | $5,043,000 | -26.6% | 65,606 | +23.1% | 0.02% | 0.0% |
| Q4 2019 | $6,870,000 | +135.8% | 53,311 | +42.5% | 0.02% | +112.5% |
| Q3 2019 | $2,914,000 | -9.0% | 37,400 | +20.3% | 0.01% | -11.1% |
| Q2 2019 | $3,203,000 | +58.3% | 31,100 | +12.7% | 0.01% | +50.0% |
| Q1 2019 | $2,023,000 | +130.4% | 27,600 | +33.3% | 0.01% | +100.0% |
| Q4 2018 | $878,000 | +1.3% | 20,700 | +12.5% | 0.00% | +50.0% |
| Q3 2018 | $867,000 | -4.4% | 18,400 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $907,000 | – | 18,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |